Effects of Polyunsaturated Fatty Acids on Mental Health by McMichael, Lauren
University of Northern Iowa 
UNI ScholarWorks 
CSBS INSPIRE Student Research & Engagement 
Conference 
2020 INSPIRE Student Research & Engagement 
Showcase 
Apr 17th, 12:00 PM - 4:00 PM 
Effects of Polyunsaturated Fatty Acids on Mental Health 
Lauren McMichael 
University of Northern Iowa 
Copyright ©2020 Lauren McMichael 
Follow this and additional works at: https://scholarworks.uni.edu/csbsresearchconf 
Let us know how access to this document benefits you 
Recommended Citation 
McMichael, Lauren, "Effects of Polyunsaturated Fatty Acids on Mental Health" (2020). CSBS INSPIRE 
Student Research & Engagement Conference. 17. 
https://scholarworks.uni.edu/csbsresearchconf/2020/all/17 
This Open Access Paper Presentation is brought to you for free and open access by the Conferences/Events at UNI 
ScholarWorks. It has been accepted for inclusion in CSBS INSPIRE Student Research & Engagement Conference by 
an authorized administrator of UNI ScholarWorks. For more information, please contact scholarworks@uni.edu. 
EFFECTS OF POLYUNSATURATED FATTY ACIDS                                                             1 
 
 
 
Effects of Polyunsaturated Fatty Acids on Mental Health 
 
 
Lauren J. McMichael 
University of Northern Iowa 
April 17, 2020 
 
 
 
 
 
 
 
 
  
 
EFFECTS OF POLYUNSATURATED FATTY ACIDS          2 
Abstract  
Depression, bipolar disorder, Alzheimer's disease, and Parkinson's Disease may be associated 
with dietary imbalances currently seen in the average Western diet. The increase in intake of 
omega-6 fatty acids is a point of concern, as evidence links disproportionate intake with inhibited 
neural membrane function and increased inflammation. This paper reviews evidence related to 
problems associated with decreased omega-3 fatty acid intake in the average Western diet. 
Evidence connects omega-3 supplementation with alleviation of symptoms of depression, bipolar 
disorder, and defiant behavior. Further research may be warranted regarding the degree of 
omega-3 deficiency in given populations of interest, such as the University of Northern Iowa. 
Further research using the Diet History Questionnaire (DHQ) from the National Institutes of 
Health to measure dietary intake is planned.  
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Effects of Polyunsaturated Fatty Acids on Mental Health 
Omega-3 and Omega-6 Fatty Acids 
Fatty acids are compounds composed of carbon chains which vary in length and contain 
both a carboxylic acid group and a methyl group in their chemical composition. They can be 
categorized as saturated, monounsaturated, or polyunsaturated, based on the number of hydrogen 
atoms the compound contains. Polyunsaturated fatty acids, categorized into either omega-3s or 
omega-6s, have divergent effects on the body despite differing only in the location of one double 
bond (Ander et al., 2003). Due to the complementary role these molecules play in the human 
body, their optimal ratio is 1:1. However, the average individual consuming a Western diet has 
an omega-6 to omega-3 ratio of nearly 16:1 (Ilardi, 2009). 
It is important to recognize the distinctions between variations of omega-3s due to their 
varying effects on the body. Docosahexaenoic acid (DHA)—found most abundantly in the 
brain— prevents phospholipid membranes in brain cells from becoming inflexible (Ilardi, 2009). 
Eicosopentaenoic acid (EPA) is necessary in the production of anti-inflammatory hormones and 
increases the reactivity of neurotransmitters (Ilardi, 2009). Alpha linolenic acid (ALA)—which 
serves as a precursor for both DHA and EPA (Brenna et al., 2009)—has beneficial effects on 
coronary artery disease and other cardiovascular diseases (Ander et al., 2003). In regard to 
chemical composition, these three molecules differ only in their shape and number of double 
bonds (Khan et al., 2015). 
Effects of Omega-3 and Omega-6 Fatty Acid Intake 
Neural Membranes 
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Polyunsaturated fatty acids have the ability to change the fluidity of neural membranes by 
changing phospholipid structure, therefore impacting the processes within the cell such as 
neurotransmitter binding, receptor activity, protein function, and affecting membrane enzymes 
(Horrobin, 1998). This change in structure occurs due to folding and bending of the membrane as 
the number of double bonds increases. DHA and EPA, composing 15-30% of neuronal and 
retinal tissue dry weight, are seen to increase membrane fluidity more so than other 
polyunsaturated fatty acids due to their high number of double bonds (6 and 5, respectively) 
(Husted & Bouzinova, 2016; Horrobin, 1998). DHA is also necessary in the cell membrane for 
production and breakdown of necessary phospholipids, axon and dendrite growth, and forming 
synaptic connections (Tanaka et al., 2012; Horrobin, 1998). Increasing omega-3 polyunsaturated 
fatty acids also increase fluidity by dislodging cholesterol from the membranes. The change in 
structure of the neural membranes affects vital cellular functions (Husted & Bouzinova, 2016).  
Neurotransmitters, along with calcium, are located within vesicles, surrounded by a 
phospholipid bilayer (Horrobin, 1998). The contents of these vesicles aim to be released and 
re-uptaken, depending on the realignment of the phospholipids. When dietary intake of omega-6 
exceeds intake of omega-3 to an extreme, membrane fluidity decreases, decreasing the binding 
of neurotransmitters to their receptors (Horrobin, 1998). Genetic factors strongly influence the 
synthesis and breakdown of phospholipids, however, a lack of intake of essential fatty acids will 
cause the phospholipids to uptake less effective fatty acids. This causes a change in the 
phospholipid function and interaction with its environment (Horrobin, 1998). 
Inflammation 
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Omega-3 polyunsaturated fatty acids are seen to decrease inflammation within the body. 
Microglial cells are cells within the central nervous system which respond to infection. These 
responses include release of proinflammatory and anti-inflammatory cytokines. An inflammatory 
response is a beneficial response to infection, however, when excess proinflammatory cytokines 
are produced, they become toxic to the neurons (Layé, 2018). This excess production leads to 
cell damage. Omega-3 polyunsaturated fatty acids limit the amount of proinflammatory 
cytokines produced in two ways: restricting the inflammatory gene expression and inducing 
anti-inflammatory lipids (Layé, 2018).  
Increase in Dietary Intake 
Omega-6s, synthesized in nuts, grains, and other plant seeds, saw a drastic increase in 
dietary intake in the Western diet immediately following a revolution in farming. This 
revolution, referred to as The Green Revolution, originated in Mexico due to increased 
investment in crop improvement (Pingali, 2012). More health focus was placed on crop genetics 
in order to increase plant yield and resistance, contributing to an increase in grain-based diets due 
to the accessibility and ease of harvesting of grains (Pingali, 2012; Ilardi, 2009). Negative health 
outcomes such as diabetes and metabolic conditions are related to the increased intake of 
omega-6 rich diets, which may be reversed by returning the omega-3 to omega-6 ratio to 1:1 
(Ilardi, 2009).  
Links to Mental Health 
Mechanisms Proposed 
The omega-3 to omega-6 ratio is important to keep in balance because in excess, 
omega-6 polyunsaturated fatty acids are associated with negative health outcomes. Omega-6 
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polyunsaturated fatty acids are seen to cause inflammation because linoleic acid, a particular 
omega-6 fatty acid, is a building block for arachidonic acid, which is a building block for 
proinflammatory leukotrienes and prostaglandins. These compounds, as well as several others, 
are often referred to as AA-derived eicosanoids and excess buildup is often associated with 
inflammatory diseases (Marion-Letellier et al., 2015).  
Given the physical effects of polyunsaturated fatty acids on phospholipids and 
inflammation, it is not surprising that consuming omega-3 fatty acids in an improper balance 
may have important negative effects on mood and mental health. The Membrane Phospholipid 
Concept of Schizophrenia attributes schizophrenic behaviors to an abnormal rate of loss of EPA 
and DHA, leading to changes in cell signaling and membrane protein function (Horrobin, 1998). 
Evidence for this concept includes reduced levels of DHA in red blood cells of schizophrenia, an 
increased rate of phospholipid breakdown in the brain of unmedicated schizophrenics, and a 
reduced maximal electro-retinogram response to light, likely due to decreased DHA availability 
for cell signaling (Horrobin, 1998). The rate at which these essential fatty acids are synthesized 
and incorporated into the brain decreases with stress, old age, male sex, and viral infections 
(Horrobin, 1998). This explains the trends in the age of onset of schizophrenia as well as the 
population who is most at risk. Despite providing great evidence, this concept fails to explain the 
delay between decreased levels of DHA and increased levels of sex hormones around puberty 
and the onset of symptoms in adult life (Horrobin, 1998).  
Similar mechanisms are seen to cause depressive symptoms. The monoamine hypothesis 
suggests that neurotransmitter function is altered, causing depression. This could further be 
explained by the evidence associating low levels of omega-3 to depression and the impact that 
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omega-3 polyunsaturated fatty acids have on neural membrane fluidity.  Depressive symptoms 
are also caused by proinflammatory cytokines, as seen in both rats and humans. This may 
explain the increase in prevalence of depression associated with the increase of omega-6 
polyunsaturated fatty acids, which are building blocks for proinflammatory compounds.  
Research is beginning to suggest that certain neurological disorders such as Alzheimer’s 
disease and Parkinson’s disease, which are related to high levels of brain inflammation, may be 
prevented by an increase of polyunsaturated fatty acids in an individual’s diet (Layé et al, 2018). 
Increased amounts of omega-3 polyunsaturated fatty acids in the blood are associated with 
decreased proinflammatory cytokine production which increased amounts of omega-6 is 
considered proinflammatory (Layé et al, 2018; Marion-Letellier et al., 2015). Animal research, 
using well controlled experimental designs, also points to this effect. As seen in perinatal mice 
and rats, decreased dietary intake of omega-3s caused microglial alteration as well as increased 
amounts of proinflammatory cytokines (Layé et al, 2018). 
Non-Experimental Human Research 
Many studies suggest that decreased levels of omega-3s are associated with mood 
disorders such as depression. Peet et al. (1997) measured amounts of fatty acids in red blood cell 
membranes in fifteen patients suffering with major depressive episodes, as defined by DSM-IV, 
and fifteen patients with no history of psychiatric or medical illness. Their study found that red 
blood cell membranes of depressive patients have decreased levels of fatty acids when compared 
to healthy patients. Reduced levels of omega-3 polyunsaturated fatty acids are also seen in red 
blood cells of patients diagnosed with bipolar disorders (Bozzatello et al., 2016).  
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Controlled experiments with participants randomly assigned to treatment conditions are 
the gold standard for determining cause and effect relationships regarding mental health 
outcomes. It is important to appreciate that the experimental control and random participant 
assignment prevents selection bias and minimizes confounding factors as explanation for effects. 
The effects of fatty acids on mental health have also been investigated using the experimental 
method. 
Experimental Human Research 
Multiple studies supplemented individuals diagnosed with bipolar disorder with EPA, 
DHA, ALA, or unspecified omega-3 fatty acids. Stoll et al. (1999) completed a 16 week study 
providing 14 participants with 6.2g of EPA and 3.4g of DHA and 16 participants with a placebo 
each day. This study is one of three which found improvement of depressive symptoms, but not 
mania. Other studies which saw improvements of the depressive side of bipolar disorder 
symptoms include studies by Frangou et al. (2006) and Gracious et al. (2010). Frangous et al. 
(2006) administered 1 or 2g per day of EPA to 75 patients, each of which continuing their 
regularly prescribed psychotropic medications. Findings were similar to that of Stoll et al. 
(1999), as depressive symptoms of bipolar disorder were improved. Gracious et al. (2010) also 
found an improvement of symptoms when ALA was administered to adolescents in tandem with 
psychotropic medications, compared to the medications alone.  
Nonetheless, the effect of omega-3 fatty acids on bipolar disorder are mixed; three other 
studies did not find significant improvement of symptoms as compared to control groups 
(Bozzatello et al., 2016). Studies which did not find any significant improvement of bipolar 
symptoms were conducted by Chiu et al. (2003), Keck et al. (2006), and Murphy et al. (2012). 
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For example, Chiu et al (2003) treated 15 participants with acute mania for four weeks with 
supplementation of 4.4g of EPA and 2.4g of DHA. The placebo group received 20mg/kg/day of 
valproate, a mood stabilizer and did not report significant improvements of manic symptoms. 
Despite mixed results between the six studies, it was seen that EPA or ALA supplementation is 
more beneficial than DHA supplementation. Finally, findings suggest that EPA should be 
administered in doses of at least 1mg in order for improvement of depressive symptoms to be 
seen (Bozzatello et al., 2016). 
Similar findings have also been demonstrated in a randomized clinical trial studying 
depression. For example, 20 children (10 experimental and 10 control) ranging from eight to 
twelve years of age, were given sixteen weeks of omega-3 treatment or placebo. Their depression 
was rated by the Children’s Depression Rating Scale (CDRS) before and after receiving 
treatment. Their results indicate that omega-3 is a successful treatment for depression in children. 
Seven out of ten children receiving the omega-3 treatment saw at least a fifty percent reduction 
in their CDRS score at the end of the sixteen weeks and three of these ten met remission criteria 
(Nemets et al., 2006). 
Young adult prisoners have also participated in randomized clinical trials which measure 
the impact of fatty acids, as well as other vitamins and minerals, on behavior. Gesch et al. (2002) 
provided 231 young adult inmates with nutritional supplements to determine the impact that 
intake of vitamins and minerals has on behavior. Antisocial behavior was measured by the 
number of infractions an inmate received. These infractions  typically comprised rule violations. 
Dietary intake was measured by food diaries completed by inmates and portion weights were 
provided by those which served the meal. Several tests were used to measure verbal ability, 
EFFECTS OF POLYUNSATURATED FATTY ACIDS          10 
cognition, emotional control, health status, and levels of anxiety and depression. Findings show 
that the group receiving true supplements reduced the number of minor reports received by 
35.1% while the placebo group reduced their minor reports by 6.7%. This suggests that dietary 
intake of vitamins, mineral, and essential fatty acids improves antisocial and defiant behaviors 
(Gesch et al., 2002). 
Conclusions and Future Research  
Though there is no definite answer for the causal mechanism between dietary intake of 
polyunsaturated fatty acids and mental health outcomes, animal research and studies of blood 
levels indicate that omega-3 fatty acids increase neural membrane fluidity and production of 
anti-inflammatory cytokines. Placebo controlled clinical trials point to the importance of 
maintaining a proper omega 3 to omega 6 ratios, as imbalances are related to negative mental 
health outcomes (Stoll et al., 1999; Nemets et al., 2006). Thus, it is not altogether surprising that 
decreasing symptoms of psychological disorders such as bipolar disorder, depression, and 
schizophrenia, as well as Parkinson’s Disease and Alzheimer's Disease may all be linked to these 
substances (Bozzatello et al., 2016; Ilardi, 2009; Nemets et al., 2006; Layé et al., 2018; Horrobin, 
1998; Dyall, 2015). An imbalance in intake of fatty acids in the average Western diet has become 
extreme, resulting from the Green Revolution providing increased reliance upon seeds and grains 
(Pingali, 2012; Ilardi, 2009). Recognizing the importance of increasing dietary intake of omega-3 
fatty acids and returning the omega-6 to omega-3 ratio back to 1:1 may aid in alleviation of 
negative mental health outcomes.  
Future research may benefit society by increasing awareness of this issue, such as by 
quantifying actual dietary intake of populations. Using the DHQ, I plan to further this project by 
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determining if students at the University of Northern Iowa may be at risk for mental health issues 
based on imbalances in dietary intake of omega-3 and omega-6 fatty acids.  
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